Tower Research Capital LLC (Trc) Chemo Centryx, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$22.17 - $51.8 $35,826 - $83,708	1,616 Added 14.88%	12,474 $644,000
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $39,659 - $71,030	2,582 Added 31.2%	10,858 $269,000
Q1 2022 May 12, 2022	SELL	$22.22 - $39.12 $134,253 - $236,363	-6,042 Reduced 42.2%	8,276 $208,000
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $35,399 - $78,003	1,926 Added 15.54%	14,318 $521,000
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $96,438 - $145,096	7,317 Added 144.18%	12,392 $211,000
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $14,471 - $76,777	1,509 Added 42.32%	5,075 $68,000
Q1 2021 May 17, 2021	BUY	$49.53 - $68.4 $110,204 - $152,190	2,225 Added 165.92%	3,566 $183,000
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $26,696 - $36,815	-565 Reduced 29.64%	1,341 $83,000
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $269,525 - $358,727	-5,815 Reduced 75.31%	1,906 $104,000
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $297,876 - $502,405	7,721 New	7,721 $444,000
Q1 2020 May 15, 2020	SELL	$32.73 - $50.78 $163,420 - $253,544	-4,993 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$6.81 - $39.55 $24,161 - $140,323	3,548 Added 245.54%	4,993 $197,000
Q3 2019 Nov 05, 2019	SELL	$6.47 - $8.96 $10,746 - $14,882	-1,661 Reduced 53.48%	1,445 $9,000
Q2 2019 Aug 13, 2019	BUY	$8.31 - $14.85 $25,810 - $46,124	3,106 New	3,106 $29,000
Q1 2019 May 14, 2019	SELL	$10.01 - $13.89 $2,572 - $3,569	-257 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $3,376 - $4,523	-369 Reduced 58.95%	257 $3,000
Q3 2018 Nov 13, 2018	SELL	$10.49 - $13.72 $64,691 - $84,611	-6,167 Reduced 90.78%	626 $8,000
Q2 2018 Aug 15, 2018	BUY	$10.62 - $13.98 $51,305 - $67,537	4,831 Added 246.23%	6,793 $89,000
Q1 2018 May 15, 2018	SELL	$5.9 - $14.99 $24,455 - $62,133	-4,145 Reduced 67.87%	1,962 $27,000
Q4 2017 Feb 09, 2018	BUY	$5.53 - $8.42 $9,102 - $13,859	1,646 Added 36.9%	6,107 $36,000
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $28,996 - $47,688	4,461	4,461 $33,000

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account